Skye Bioscience, Inc. (SKYE)
0.857
+0.01
(+0.82%)
USD |
NASDAQ |
Dec 24, 12:59
0.857
0.00 (0.00%)
After-Hours: 13:59
Skye Bioscience SG&A Expense (TTM): 16.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 31.53M |
| Theravance Biopharma, Inc. | 75.94M |
| Viking Therapeutics, Inc. | 52.36M |
| FibroGen, Inc. | 28.80M |
| Myomo, Inc. | 32.71M |